American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Jeffrey R CurtisSindhu R JohnsonDonald D AnthonyReuben J ArasaratnamLindsey R BadenAnne R BassCassandra CalabreseEllen M GravalleseRafael HarpazRebecca E SadunAmy S TurnerEleanor Anderson WilliamsTed R MikulsPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.
Keyphrases
- coronavirus disease
- healthcare
- sars cov
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- rheumatoid arthritis
- primary care
- juvenile idiopathic arthritis
- peritoneal dialysis
- prognostic factors
- electronic health record
- respiratory syndrome coronavirus
- big data
- patient reported
- psychometric properties